Full notification file
General informationNotification NumberB/BE/07/BVW3Member State to which the notification was sentBelgiumDate of acknowledgement from the Member State Competent Authority03/12/2007Title of the ProjectA multi-centre phase I study to evaluate the safety and tolerability of a heterologous prime-boost vaccination with INX102-3697 HBV pDNA/INX-102-00557 HBV MVA in healthy volunteers and HBeAg+ chronic hepatitis patientsProposed period of release:01/03/2008 to 01/03/2010Name of the Institute(s) or Company(ies)GENimmune N.V., ;
3. Is the same GMO release planned elsewhere in the Community?NoHas the same GMPt been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:DNA VirusIdentity of the GMO:Modified Vaccinia virus Ankara (MVA), strain MVATGN33Information relating to the recipient or parental organisms from wich the GMO is derived| Common Name | Genus | Species | Subspecies | Strain | Pathovar | | MVA | Orthopoxvirus | Vaccinia virus | | Modified Virus Ankara | |
|
European Commission administrative informationConsent given by the Member State Competent Authority:Not known